Nano Dimension to Acquire Infinite Epigenetics for $890M

Nano Dimension Ltd. has entered into a non-binding term sheet to acquire Infinite Epigenetics, Inc. in a proposed business combination. The transaction, valued at $890 million for Infinite Epigenetics, will be structured as a stock-for-stock merger, with existing Nano Dimension shareholders expected to retain a meaningful minority ownership in the combined entity. The combined company will operate under the Infinite Epigenetics name and trade on Nasdaq under the ticker symbol IEAI. The deal includes binding exclusivity provisions and a potential expense reimbursement for Infinite Epigenetics if a definitive agreement is not reached by a specific date.